TITLE

Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis

AUTHOR(S)
Carr, Brian; Guerra, Vito; Carr, Brian I
PUB. DATE
March 2016
SOURCE
Digestive Diseases & Sciences;Mar2016, Vol. 61 Issue 3, p937
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Macroscopic portal vein thrombosis (PVT) is a common and dire prognostic feature of patients with hepatocellular carcinoma (HCC) and often precludes many treatments as a result. Little is known about its causes or mechanisms or clinical associations.Aims: To examine patients with PVT in order to possibly identify prognostically different subsets.Methods: A large cohort of non-curable patients with advanced and biopsy-proven HCC in which survival was documented, were retrospectively examined.Results: We analyzed a large HCC cohort containing 366 (63.3%) PVT-positive patients and found that PVT is associated with patients having larger tumors and higher levels of alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP). We identified in patients with normal bilirubin levels (≤ 2.0 mg/dl) two PVT-positive patients, having higher and lower AFP levels, respectively. They differed in the significantly better prognosis of the low AFP patients, which may be useful for patient management decisions.Conclusions: Patients with PVT are heterogeneous with respect to AFP levels. AFP-negative patients have a significantly better survival than those who have elevated AFP.
ACCESSION #
113205137

 

Related Articles

  • Expression of Yes-associated protein in liver cancer and its correlation with clinicopathological features and prognosis of liver cancer patients. Yi-Ping Wang; Dong-Xin Tang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 1, p1080 

    Objective: To investigate the expression of Yes-associated protein (YAP) in liver cancer and its correlation with clinicopathological features and prognosis of liver cancer patients. Methods: A total of 95 patients receiving surgery due to liver cancer were recruited. Results: In 95 liver...

  • The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma. Okamura, Yukiyasu; Ashida, Ryo; Ito, Takaaki; Sugiura, Teiichi; Mori, Keita; Uesaka, Katsuhiko // Surgery Today;Dec2015, Vol. 45 Issue 12, p1513 

    Purpose: Alpha-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) are prognostic factors for hepatocellular carcinoma (HCC). The impact of these tumor markers in recurrent HCC on the prognosis remains to be fully elucidated. Methods: Two hundred and seventeen patients whose AFP and DCP...

  • Microvascular invasion (MVI) is a prognostic predictor for small hepatocellular carcinoma. Min Du; Lingli Chen; Jing Zhao; Feng Tian; Haiying Zeng; Yunshan Tan; Huichuan Sun; Jian Zhou; Yuan Ji // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Small hepatocellular carcinoma (SHCC) is a special type of hepatocellular carcinoma with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. However, the prognostic factors for SHCC remain controversial. The purpose of this study is to clarify the predictive...

  • Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study. Hong, Thai P.; Gow, Paul J.; Fink, Michael; Dev, Anouk; Roberts, Stuart K.; Nicoll, Amanda; Lubel, John S.; Kronborg, Ian; Arachchi, Niranjan; Ryan, Marno; Kemp, William W.; Knight, Virginia; Sundararajan, Vijaya; Desmond, Paul; Thompson, Alexander J. V.; Bell, Sally J. // Medical Journal of Australia;10/15/2018, Vol. 209 Issue 8, p1 

    Objectives: To determine the factors associated with survival of patients with hepatocellular carcinoma (HCC) and the effect of HCC surveillance on survival. Design, setting and participants: Prospective population-based cohort study of patients newly diagnosed with HCC in seven tertiary...

  • Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis. JINGBO KANG; QING NIE; RUI DU; LIPING ZHANG; JUN ZHANG; QILIANG LI; JIANGUO LI; WENJIE QI // Molecular & Clinical Oncology;2014, Vol. 2 Issue 1, p43 

    The purpose of this study was to evaluate the clinical efficacy, toxicity and adverse effects of stereotactic body radiotherapy (SBRT) combined with transarterial chemoembolization (TACE) in patients with advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). A total...

  • In Hepatocellular Carcinomas, any Proportion of Poorly Differentiated Components is Associated with Poor Prognosis After Hepatectomy. Sasaki, Kazunari; Matsuda, Masamichi; Ohkura, Yu; Kawamura, Yusuke; Inoue, Masafumi; Hashimoto, Masaji; Ikeda, Kenji; Kumada, Hiromitsu; Watanabe, Goro // World Journal of Surgery;May2014, Vol. 38 Issue 5, p1147 

    Background: Hepatocellular carcinoma (HCC) often consists of various differentiation components in a single tumor. However, the categorization of histologic grade in hepatectomy for those tumors has not been standardized. Some studies have determined the differentiation grade of the tumor...

  • Liver cancer. Gravitz, Lauren // Nature;12/4/2014 Supplement, Vol. 516 Issue s7529, pS1 

    The article offers an introduction to the issue in which the editor discusses liver cancer, its diagnosis and survival rates of patients who contract it.

  • Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma. Alkhalili, Eyas; Greenbaum, Alissa; Li Luo; Rodriguez, Rodrigo; Caldwell, Katharine; Estrada, Oscar Munoz; O'Neill, Jacqueline; Nir, Itzhak; Morris, Katherine T. // Annals of Gastroenterology;2017, Vol. 30 Issue 1, p101 

    Background: There have been few studies on the impact of viral etiology on the prognosis in patients with hepatocellular carcinoma (HCC). The aim of this study was to evaluate the clinical characteristics and survival of patients with viral hepatitis-associated HCC (V-HCC), compared to patients...

  • Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. Yong Kang Lee; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Kwang Hun Lee; Do Yun Lee; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background/Aims: Alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) have been used as diagnostic tools for hepatocellular carcinoma (HCC). However, prediction of outcome using AFP and DCP has not been elucidated. We investigated the clinical role of AFP and DCP as predictors of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics